Estrella Immunopharma Balance Sheet (2021-2026)

Reported Financials

Estrella Immunopharma Quarterly Balance Sheet

Periods 22 quarters

Latest Jun 2026

Estrella Immunopharma reported total assets of $1.82M and total liabilities of $9.26M for the quarter ended Jun 2026, down 38.8% year over year. This balance sheet covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.32M	0.48M	0.32M	0.09M	0.07M	0.04M	0.03M	2.48M	22.14M	9.05M	4.73M	4.17M	1.80M	0.92M	0.42M	1.32M	1.63M	1.38M	1.93M	0.15M
Cash & Current Investments	0.32M	0.48M	0.32M	0.09M	0.07M	0.04M	0.03M	2.48M	22.14M	9.05M	4.73M	4.17M	1.80M	0.92M	0.42M	1.32M	1.63M	1.38M	1.93M	0.15M
Receivables - NetNet Receivables								0.27M	0.27M
Receivables								0.27M	0.27M
Prepaid Assets	0.01M	0.14M	0.11M	0.04M	0.09M	0.01M	0.05M	0.09M	0.14M	0.40M	3.50M	0.29M	0.44M	0.72M	0.52M	0.16M	0.40M	0.29M	0.23M	0.18M
Current Assets	0.78M	0.62M	0.43M	0.13M	0.16M	0.05M	0.08M	2.75M		9.45M	8.63M	4.45M	2.24M	1.64M	0.94M	1.48M	2.02M	1.68M	2.16M	1.82M
Non-Current Assets
Long-Term Investments	45.19M	45.19M	45.19M	45.26M	45.46M	9.67M	9.70M	9.79M	5.10M	0.05M	0.05M	0.05M	0.05M
Long-Term Deferred Tax						0.26M		0.34M
Other Non-Current Assets								0.28M	27.35M				1.50M	1.50M	1.50M	1.50M	1.50M	1.50M	1.50M
Non-Current Assets	45.19M	45.19M	45.19M	45.26M	45.46M	9.67M	9.70M	0.28M					1.50M	1.50M	1.50M	1.50M	1.50M	1.50M	1.50M
Assets	45.97M	45.80M	45.62M	45.38M	45.62M	9.72M	9.78M	3.03M	27.35M	9.45M	8.63M	4.45M	3.74M	3.14M	2.44M	2.98M	3.52M	3.18M	3.66M	1.82M
Liabilities
Current Liabilities
Accounts Payables	0.00M	0.00M	0.01M	0.11M	0.21M	0.33M	0.38M	0.44M	9.34M	0.08M			0.01M	0.00M	0.01M	0.01M	0.01M	0.55M	0.01M	0.01M
Notes Payables					0.50M	0.05M	0.14M	0.27M	0.30M							0.19M	0.39M	0.36M	0.47M	0.69M
Payables	0.00M	0.00M	0.01M	0.11M	0.71M	0.38M	0.51M	0.71M	9.64M	0.08M			0.01M	0.00M	0.01M	0.20M	0.39M	0.91M	0.48M	0.70M
Accumulated Expenses								0.40M	2.50M	0.27M	0.17M	0.13M	0.19M	2.80M	0.12M	8.80M	12.90M	0.24M	0.18M	0.26M
Other Accumulated Expenses								0.02M	0.02M	0.00M	391.00	347.00	0.00M	0.01M	0.00M			0.02M	0.00M	0.00M
Current Taxes						0.05M	0.09M	0.00M	5.07M	0.04M	0.04M	0.04M	0.04M	50.00	50.00
Total Current Liabilities	0.10M	0.07M	0.03M	0.15M	0.74M	1.07M	1.22M	9.76M	17.28M	0.40M	0.14M	0.18M	2.99M	3.00M	4.28M	9.08M	13.36M	13.54M	8.93M	9.30M
Non-Current Liabilities
Preferred Stock Liabilities	45.19M	45.19M	45.19M	45.19M	45.32M	9.33M	9.54M	9.75M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax						0.03M	0.01M	0.01M
Other Non-Current Liabilities								0.01M						0.32M		0.19M	0.39M	0.36M	0.47M	0.69M
Total Non-Current Liabilities								0.01M	17.28M	0.40M	0.14M	0.18M	2.99M	2.68M		8.89M	12.97M	13.19M	8.46M	8.57M
Total Liabilities	1.65M	1.62M	1.58M	1.71M	2.29M	2.65M	2.77M	9.77M	17.28M	0.40M	0.14M	0.18M	2.99M	3.00M	4.28M	9.08M	13.36M	13.54M	8.93M	9.26M
Shareholder's Equity
Total Debt					0.50M	0.05M	0.14M	0.27M	0.30M							0.19M	0.39M	0.36M	0.47M	0.69M
Common Equity	-0.87M	-1.01M	-1.15M	-1.04M	-3.82M	-6.48M	-9.11M	-11.74M	10.07M	9.05M	8.49M	4.27M	0.75M	0.14M	-1.83M	-6.09M	-9.84M	-10.37M	-5.27M	-7.43M
Liabilities and Shareholders Equity	45.97M	45.80M	45.62M	45.38M	45.62M	9.72M	9.78M	3.03M	27.35M	9.45M	8.63M	4.45M	3.74M	3.14M	2.44M	2.98M	3.52M	3.18M	3.66M	1.82M
Treasury Shares	4.43M	4.43M	4.43M	4.43M	4.43M	0.91M	0.91M				0.07M	0.32M	0.43M	0.49M	0.52M	0.52M	0.52M	0.52M	0.52M	0.52M
Retained Earnings	-0.87M	-1.01M	-1.15M	-1.51M	-1.98M	-2.26M	-2.53M	-12.19M	24.12M	24.12M	24.12M	24.12M	24.12M	24.64M	-26.03M	-31.60M	-36.40M	-36.99M	-39.30M	-41.60M
Preferred Shares				105.00M				5.00M		0.50M	0.50M	0.50M	0.50M

Estrella Immunopharma ESLA Balance Sheet (2021-2026)

Estrella Immunopharma Quarterly Balance Sheet

Create an account

Sign In

Reset Password